BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15909956)

  • 1. Antitumor in vitro evaluation of certain derivatives of pyrido-1,2-thiazines.
    Malinka W; Kaczmarz M; Redzicka A
    Acta Pol Pharm; 2004 Dec; 61 Suppl():100-2. PubMed ID: 15909956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
    Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
    Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activity of some pyrido-1,2-thiazine derivatives.
    Malinka W; Redzicka A; Swiatek P
    Acta Pol Pharm; 2002; 59(6):439-42. PubMed ID: 12669767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activity of some isothiazolo[5,4-b]pyridine derivatives.
    Swiatek P; Malinka W
    Acta Pol Pharm; 2004 Dec; 61 Suppl():98-100. PubMed ID: 15909955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
    Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
    Rostom SA; Hassan GS; El-Subbagh HI
    Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzimidazole condensed ring systems 10 (1). Synthesis and cytotoxic activity of some pyrido[1,2-a]benzimidazoles.
    Badawey ES; Kappe T
    Farmaco; 1995; 50(7-8):537-42. PubMed ID: 7669192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
    Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
    J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrido-1,2-thiazines and their in vitro antibacterial evaluation.
    Malinka W; Gamian A; Redzicka A; Swiatek P
    Acta Pol Pharm; 2008; 65(1):71-4. PubMed ID: 18536176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides.
    Brzozowski Z; Saczewski F; Neamati N
    Bioorg Med Chem; 2006 May; 14(9):2985-93. PubMed ID: 16406643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives.
    el-Hawash SA; Badawey el-S A; Kappe T
    Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
    Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
    Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity.
    Borcard F; Baud M; Bello C; Dal Bello G; Grossi F; Pronzato P; Cea M; Nencioni A; Vogel P
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5353-6. PubMed ID: 20688516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycle.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Lima RT; Vasconcelos MH
    Eur J Med Chem; 2010 Dec; 45(12):5628-34. PubMed ID: 20926160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors.
    Kuo GH; Deangelis A; Emanuel S; Wang A; Zhang Y; Connolly PJ; Chen X; Gruninger RH; Rugg C; Fuentes-Pesquera A; Middleton SA; Jolliffe L; Murray WV
    J Med Chem; 2005 Jul; 48(14):4535-46. PubMed ID: 15999992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
    Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
    Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
    Abdel-Aziz HA; Saleh TS; El-Zahabi HS
    Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.